Dividing the population in this way provides cohorts with sufficient N to allow for survival analysis across scales of relative invasiveness whereas progression-free survival data, available in 102 patients but failed to reach significance in either the overall or sub cohorts.
← all excerpts
Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.
1
—
—